Skip to content

Evaluation of a Smoking Cessation Program for Long-Term Abstinence

Observational Study Evaluating a Smoking Cessation Program and Its Association With Long-Term Smoking Abstinence

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06746025
Acronym
ESCaPe
Enrollment
371
Registered
2024-12-24
Start date
2024-10-28
Completion date
2026-07-25
Last updated
2026-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nicotine Addiction, Smoking Cessation

Keywords

smoking, quit smoking, addiction

Brief summary

This observational study evaluates a structured smoking cessation program delivered via weekly group sessions. The primary objective is to assess participant-reported smoking abstinence following completion of the program and at 6-month follow-up. Secondary objectives include evaluating changes in self-reported anxiety related to smoking cessation and assessing whether participants report reduced need for ongoing trigger management. The study will also characterize the demographic profile of participants enrolled in the program. Participants will attend weekly 1-hour group sessions conducted via videoconference over an 8-week period. Data collection includes a baseline demographic questionnaire, an end-of-program questionnaire, and a 6-month follow-up questionnaire assessing continued smoking status and related measures. All study activities are conducted remotely, and participants may be located anywhere within the United States.

Detailed description

This observational study evaluates a structured, group-based smoking cessation program delivered remotely to adult participants residing in the United States. The program is conducted via weekly videoconference sessions and may be offered in both English and Spanish to accommodate participant language needs. Eligible participants include individuals who currently use combustible cigarettes and/or electronic nicotine delivery systems (vaping products) and who are interested in attempting smoking cessation. Participants will be enrolled in an 8-week program consisting of weekly 1-hour group sessions, with approximately 15-20 participants per group. The program is behavioral and educational in nature and does not include pharmacologic interventions or nicotine replacement therapies. Sessions are designed to provide participants with strategies intended to support smoking cessation through behavioral change, peer support, and self-directed techniques. The group-based format is intended to provide a supportive environment that may facilitate engagement and adherence to the program. Data collection includes baseline demographic information, end-of-program assessment, and a 4-to-6 month follow-up evaluation. Outcome measures focus on participant-reported smoking status, as well as self-reported changes in anxiety related to smoking cessation and perceived need for ongoing trigger management. The study does not evaluate the health benefits of smoking cessation, which are well established in the existing literature. Rather, the focus of this study is to assess participant outcomes associated with participation in the program and to describe the characteristics of individuals who engage in this intervention.

Interventions

BEHAVIORALQuit Center cessation program

A structured, group-based smoking cessation program delivered remotely through weekly 1-hour videoconference sessions over 8 weeks. The program is behavioral and educational in nature and is intended to support smoking cessation through behavioral change strategies, peer support, and self-directed techniques. The program does not include pharmacologic interventions or nicotine replacement therapies.

Sponsors

Quit Center LLC
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. must be addicted to nicotine either by cigarette or vaping 2. must have access to an internet connected device, laptop, or smartphone 3. must be 18 years old or older

Exclusion criteria

1. currently enrolled in any weight-loss program 2. currently enrolled in any behavioral modification program 3. currently using nicotine replacement therapy of any kind

Design outcomes

Primary

MeasureTime frameDescription
Smoking Abstinence at End of Program8 WeeksPercentage of participants who self-report abstinence from smoking and/or vaping at the end of the 8-week program.

Secondary

MeasureTime frameDescription
Self-reported Tobacco Abstinence at 4-6 Months Post-program4-6 months post-program completionParticipants who self-reported abstinence from tobacco use at follow-up conducted between 4 and 6 months after completion of the 8-week program.

Countries

United States

Contacts

STUDY_DIRECTORRichard Rubino

Quit Center LLC, Managing Member

Participant flow

Recruitment details

Approximately 2,500 individuals expressed interest in participating in the study. Of these, approximately 2,000 were excluded based on failure to meet inclusion criteria or the presence of one or more exclusion criteria. The remaining eligible individuals were considered for enrollment, of whom 371 were enrolled in the program.

Pre-assignment details

Participants were enrolled in a structured 8-week smoking cessation program. Details regarding participant progression and completion are provided in the Participant Flow section.

Baseline characteristics

Characteristic
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
341 Participants
Sex: Female, Male
Female
147 Participants
Sex: Female, Male
Male
194 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 0
other
Total, other adverse events
0 / 0
serious
Total, serious adverse events
0 / 0

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 18, 2026